MilliporeSigma

Company Legal / IP

MilliporeSigma Avoids Prosecution in Biochemical Diversion Case: A DoJ First

Fineline Cube May 23, 2024

Merck KGaA (NYSE: MRK)’s US life sciences division, MilliporeSigma, has been at the center of...

Policy / Regulatory

U.S. Tariffs on Pharmaceuticals and Their Impact on China’s Medical Industry

Company Drug

Sichuan Biokin Launches Phase III Trial for BL-B01D1 in Urothelial Carcinoma

Company Drug

AbbVie’s Rinvoq Approved in EU for Giant Cell Arteritis

Company Drug

Bristol-Myers Squibb’s Opdivo/Yervoy Combo Approved for MSI-H Colorectal Cancer